Abstract
INTRODUCTION
Helicobacter pylori (H. pylori) is a gram-negative bacterium found on the luminal surface of the gastric epithelium. It was first isolated by Warren and Marshall in 1983. It induces chronic inflammation of the underlying mucosa. The infection is usually contracted in the first few years of life and tends to persist indefinitely unless treated. At least 50% of the world's population is thought to carry H. pylori. The organism can survive in the acidic environment of the stomach partly owing to its remarkably high urease activity. Urease converts the urea present in gastric juice to alkaline ammonia and carbon dioxide [1] . Although the full spectrum of pathogenesis is currently unknown, H. pylori has been linked to a variety of upper gastrointestinal disorders. Reported symptoms of H. pylori infection are relatively nonspecific, such as epigastric pain, postprandial fullness, bloating, nausea, and vomiting, along with signs of acid hypersecretion and delayed gastric emptying [2, 3] . In addition, infection with H. pylori is linked to three important upper gastrointestinal diseases: duodenal or gastric ulcers, gastric cancer, and gastric mucosaassociated lymphoid-tissue lymphoma.
Many invasive and non-invasive methods can be used to diagnose H. pylori infection, including endoscopy with biopsy, serology for immunoglobulin titers, stool antigen analysis, and the urea breath test (UBT). Given the user-friendly, non-invasive features of UBT, this detection method may be preferred in many clinical settings. However, to date, the performance characteristics of UBT have been inconsistently described and remain incompletely defined.
UBT can play a useful role in the diagnostic evaluation of dyspeptic patients who have comorbidities that increase their risk of upper endoscopy, are intolerant to upper endoscopy, or have known or suspected gastric atrophy. Stool antigen testing can also be used to non-invasively detect active H. pylori infection, and the choice of diagnostic modality depends on factors such as cost, laboratory infrastructure, and concomitant use of medications such as proton pump inhibitors or antibiotics that may influence test results. Serum antibody test results can vary by geographic region, and may stay positive for a prolonged period following H. pylori eradication, thereby limiting the clinical utility for determining the presence or absence of current infection [4] . There are two UBTs available and gained Food and Drug Administration approval: 13 C and 14 C tests. Both tests are affordable and can provide real-time results. Some physicians may prefer the 13 C test as it is nonradioactive compared to 14 C which uses a radioactive isotope, especially in young children and pregnant women, though dose of radianis very minimal (about 1 microCi) [5] ; the dose of radiation is the dose of 14 C-UBT with the mini dose equals to 1 microCi (37 kbq) which has a high diagnostic accuracy [6] . UBT is indicated to confirm H. pylori colonization and to monitor its eradication. Positive UBT indicates an active H. pylori infection which require treatment or further confirmation with invasive procedures. Initial treatment for H. Pylori consist of either triple, quadruple, or sequential therapy regimens, which all of them includes a proton pump inhibitor plus various antibiotic regimen; treatment periods generally varied from 7 to 14 d [4] . In this systematic review and meta-analysis, we aimed at summarizing data and appraising the relevant articles of UBT for diagnosis of H. pylori infection in dyspeptic patients and provide pooled diagnostic accuracy measures.
MATERIALS AND METHODS
Search and analysis methods, eligibility criteria, and the outcomes of interest were specified in advance in a protocol developed by study investigators.
Inclusion criteria
We included cross-sectional studies with consecutive patients that evaluated the diagnostic accuracy of UBT in adult patients with dyspeptic symptoms. We included articles that compare 13 C-UBT or 14 We excluded studies that enrolled children or adolescents under 18 year of age, subjects who presented for reasons other than dyspeptic symptoms, bleeding peptic ulcer, complicated dyspeptic cases that need surgery, those who received previous therapy for H. pylori within the last 3 mo, or long term use of corticosteroids and immunosuppressant drugs and screening studies. Only articles presenting true positive, true negative, false positive and false negative data were included in the present study. Studies where data was missing and studies with high risk of bias were excluded.
C-UBT

UBT variants
There was no inclusion restriction on the type of UBT performed. Both 
Search strategy
A librarian searched electronic databases for published and in-press studies from 1990 (the date where UBT became available) through November 2013 including PubMed, EMBASE, LILACS and Cochrane databases. The search terms used were "H. pylori", "Helicobacter pylori", "Helicobacter infection", "gastritis", "dyspepsia", "breath test", "urea breath test", "UBT", " 
Study and data selection
Two authors (MF, WM) screened titles and abstracts for inclusion criteria. Full text articles were retrieved for relevant articles. An abstraction format developed by authors that includes: study citation, author name and year of publication, patients' mean age and other baseline characteristics, UBT variant, gold standard used, time between the test and gold standard, description of the cases, and diagnostic study data (numbers of true positive, false positive, false negative, and true negative test results). Disagreement was resolved by consensus.
Quality assessment
Two reviewers (MF and IY) independently assessed the quality of the included studies using the QUADAS (Quality Assessment of Diagnostic Accuracy Studies)-2 instrument [7] . This tool is designed to assess the quality of primary diagnostic accuracy studies for inclusion in the systematic review. It consists of four key domains covering patient selection, index test, reference standard, and flow of patients through the study and timing of the index test(s) and reference standard. Each domain is assessed in terms of the risk of bias and the first three are also assessed in terms of concerns regarding applicability. Risk of bias is judged as "low", "high", or "unclear". If all signaling questions for a domain are answered "yes" then risk of bias can be judged "low". If any signaling question is answered "no" this flags the potential for bias.
We considered low risk of bias in different domains as follows: Patient selection if non-complicated dyspeptic patients were enrolled in consecutively. Index test, where it was interpreted independent from the reference standard. Reference standard, when it correctly classifies H. pylori and non-H. pylori. Flow and time, the appropriate interval between index test and the reference standard is within 7 d, and breathing samples were collected within 30 min.
Meta-analysis
The meta-analysis was conducted using MetaDisc 1.4 [8] . Random effect model was followed in all analyses. The diagnostic accuracy measures used in the analysis were sensitivity, specificity, likelihood ratio for positive and negative test (LR+ and LR-), receiver operating characteristics (ROC) curve, and diagnostic odds ratio. We assessed heterogeneity using the I-squared statistic and Q test. Publication bias was conducted using the Deeks' funnel plot asymmetry test, with P-value < 0.05 for the slope coefficient indicating significant asymmetry [9] .
Subgroup and sensitivity analyses
To explore the robustness of our results and evaluate for potential causes of heterogeneity, we conducted several a priori determined analyses. We tested the bivariate mixed effects regression model to determine if results were robust to the correlation between sensitivity and specificity. Bivariate analysis were conducted as implemented in STATA version 12.0 (StataCorp, College Station, TX, United States) [10] . We also conducted subgroup analyses based on the risk of bias in the included studies as it pertains to the various domains of QUADAS-2 tool (such as for the index test and the gold standard test). We evaluated if the type of UBT test ( 13 C vs 14 C) or measurement technique (isotope ration mass spectrometry vs infrared mass spectrometry) affected the pooled estimates. We conducted an interaction test for subgroup analyses as suggested by Altman and Bland [11] and there was no statistically significant difference to suggest a subgroup effect. studies (39%) used 14 C UBT. The included studies were conducted in 16 countries, however all but one were published in English (Spanish) [12] . The mean age across studies was (40-59 year) and female gender distribution was (13%-74%).
There was variation (10 folds) in the type of reference standard tests used by different studies (Table 2 ). Seven studies (30.4%) used one reference standard starting with either histopathology or culture at first and only used subsequent tests if the first test was negative (histopathology in three studies [13] [14] [15] , and culture in four studies [16] [17] [18] [19] ). Two studies (8.7%) [20, 21] used histopathology or culture, nine studies (39.1%) [12, [22] [23] [24] used two combined tests (histopathology and rapid urease test "RUT" in four studies, histopathology and serology in one study [25] , histopathology and culture in one study [26] , and any two tests in three studies [27] [28] [29] . Four studies (17.4%) [30] [31] [32] [33] used three combined tests, and one study (4.3%) [3] used four combined tests as reference standard. Histopathology is the most common approach when combined tests were used. In three studies [3, 27, 31] , UBT was part of combined reference standards.
Pooled estimate for UBT (Combined 13 C and 14 C)
UBT had high sensitivity and specificity 0. Figure 3 . There was no evidence of publication bias (P > 0.05 using Deeks' asymmetry test).
Test of heterogeneity
Inconsistency between results for sensitivity and specificity among studies were 72.9% and 72% respectively with statistically significant Q test (P < 0.05). Heterogeneity could be explained by either clinical or methodological variation; the performed subgroup analyses could not explain the difference.
Subgroup analysis
13
C UBT vs 14 C UBT: Of the total studies recruited in this systematic review, 14 were conducted using 13 C UBT vs 9 using 14 C UBT (Table 3 ). Both versions of the test showed high performance against the Gold standard test without a significant difference. Figures are shown in online supplement materials (Figure 3 ). Interaction test for subgroup analyses as suggested by Altman and Bland [11] showed no statistically significant difference to suggest a subgroup effect (P = 0.87).
Use of infrared in UBT:
Out of total 23 studies, 6 studies used infrared technique in measuring urea level. Both methods showed high performance against the gold standard test without a significant difference. Subgroup analysis based on the risk
RESULTS
Search results
The initial search yielded 1380 studies that were potentially relevant; of which, 23 studies that enrolled a total of 3999 participants were finally included. The study selection process is depicted in Figure  1 including causes of exclusion. More than 50% of quality assessment items articles have low risk of bias of all domains. The agreement between risk of bias assessment between reviewers were 70%, disagreement was resolved by discussion and consensus. Figure 2 visually summarizes the risk of biasin the included studies. There was no significant difference in diagnostic accuracy measures based on the risk of bias in terms of the key domains of patient selection, index test, reference standard, and flow of patients through the study and timing of the index test and reference standard. Interaction test for subgroup analyses showed no statistically significant difference to suggest a subgroup effect (P = 0.23).
Characteristics of included studies
Sensitivity analysis using bivariate model: Diagnostic accuracy measures were similar under the bivariate model and meta-analysis results appeared robust to the choice of model.
DISCUSSION
UBT is a noninvasive test for diagnosis of gastric H. pylori infection. Twenty-three studies for both UBT 13 adults were included. The result of the meta-analysis showed that the test performance was high and the test has significant discrimination power between those who have the infection and those who haven't. The quality of this evidence is considered moderate due to the presence of heterogeneity, which may be explained by using different types of reference standards, timing between ingestion of the capsule and testand may be due to the variation in the methodological quality of the included studies It is very likely that the test performance is different across patients with varying pre-test risk although our analysis could not detect such difference. This analysis, focused on adults, shows similar diagnostic accuracy measures to those found in a different meta-analysis in children (sensitivity of 0.95 and specificity of 0.94 in children) [34] . In addition to the non-invasive nature of UBT, it offers the advantage of providing a comprehensive assessment that is not reliant upon the possible sampling error associated with endoscopic biopsy, due to patchy distribution of H. pylori [15] . Other limitations of the biopsy-based tests relate to their dependency on the pathologist skill and experience with studies documenting intern observer variability [35, 36] . On the other hand, there are some limitations for UBT. For example, UBT results can be affected by exposure to H. pylori therapy such as, antibiotics, proton pump inhibitors or bismuth. It requires specialized equipment for carbon dioxide measurement and infrastructure to manage radioactive materials, and it is an expensive test.
Strengths and limitations
The primary strength of this study relates to the search of electronic databases for relevant articles and the careful appraisal of study quality. The limitations mainly relate to dealing with aggregate data that limits our ability to provide estimates based on patient-level characteristics and pre-test risk level. Another significant limitation relates to heterogeneity that was unexplained despite multiple subgroup analyses. The observed heterogeneity can be attributed to several factors. The urease activity of the oral flora can affect the reading of the UBT; this can be accounted for by asking the patient to wash the mouth before conducting the test. Other authors suggested the use of Nasogastric tube. The cut off value and the time to take the reading after the meal ingestion was not clearly stated in many of the studies involved. The nature of the radioisotope meal and individual patient characteristics such as anthropometric measures, sex and age might have also contributed to within as well as between studies variability. All these factors could have contributed to the persistence of heterogeneity even after adjusting for UBT type ( 13 C vs 14 C) and technique of measurement (radioisotope mass spectrometry vs infrared spectrometry) in subgroup analysis.
In conclusion, UBT has high diagnostic accuracy for detecting H. pylori infection in patients with dyspepsia. Given the clinically significant, potentially preventable diseases associated with chronic, untreated H. pylori infection (such as gastric adenocarcinoma), more widespread adoption of UBT testing may be indicated to simultaneously improve public health and reduce treatment expense. The reliability of diagnostic meta-analytic estimates however is limited by significant heterogeneity, and the findings from this study should therefore be interpreted with appropriate caution.
COMMENTS
Background
Helicobacter pylori (H. pylori) is a gram-negative bacterium found on the luminal surface of the gastric epithelium and induces chronic inflammation of the underlying mucosa. The organism can survive in the acidic environment of the stomach partly owing to its remarkably high urease activity. Urease converts the urea present in gastric juice to alkaline ammonia and carbon dioxide. Urea 28 81 Ozdemir et al [28] 57 0 2 30 89 Oztürk et al [15] 48 5 0 20 73 Peng et al [19] 53 7 0 40 100 Perri et al [20] 121 1 5 46 173 Kopański et al [3] 75 2 0 17 94 Rasool et al [24] 61 2 5 26 94 Riepl et al [33] 30 7 7 63 107 Surveyor et al [21] 30 2 2 25 59 Valdeperez et al [12] 
Research frontiers
There are two UBTs available and gained Food and Drug Administration approval: 13 C and 14 C tests. Both tests are affordable and can provide realtime results. UBT is indicated to confirm H. pylori colonization and to monitor its eradication.
Innovations and breakthroughs
Many invasive and non-invasive methods can be used to diagnose H. pylori infection, including endoscopy with biopsy, serology for immunoglobulin titers, stool antigen analysis, and the UBT. Given the user-friendly, non-invasive features of UBT, this detection method may be preferred in many clinical settings.
Applications
UBT can play a useful role in the diagnostic evaluation of dyspeptic patients who have comorbidities that increase their risk of upper endoscopy, are intolerant to upper endoscopy, or have known or suspected gastric atrophy. The study results suggest that UBT has high diagnostic accuracy for detecting H. pylori infection in patients with dyspepsia.
Peer review
This systematic review has been well performed; with a well expressed objective, precise criteria for the studies included and the relevant studies which have been selected for further evaluation. The quality of each included study has been properly evaluated. Its main drawback is the heterogeneity of the included studies; this, however, is not the fault of the authors of the metaanalysis.
